[放射性物质（32P和89Sr）治疗骨转移疼痛]
[Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
作者信息
Flamm J, Burkert S
出版信息
Z Urol Nephrol. 1981 Nov;74(11):801-6.
PMID:6172913
Abstract
In the urological department of the Wilhelminenspital altogether 22 patients with incurable bone pains in metastasizing carcinoma were treated with radioisotopes between 1976 and 1980. 32P and 89Sr were used in a dosage of 3 times 3 mCi and once 1 mCi. A reaction to the therapy could be proved in 46%, in 23% the success could be estimated as very good. Clinic and therapy were discussed with the help of own cases and literature.
摘要
1976年至1980年间，在威廉明嫩医院泌尿外科，共有22例转移性癌引起无法治愈的骨痛患者接受了放射性同位素治疗。使用了32P和89Sr，剂量分别为3次3毫居里和1次1毫居里。46%的患者对治疗有反应，23%的患者治疗效果被评估为非常好。结合自身病例和文献对临床情况及治疗方法进行了讨论。
相似文献
1
[Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].[放射性物质（32P和89Sr）治疗骨转移疼痛]
Z Urol Nephrol. 1981 Nov;74(11):801-6.
2
Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.32P与89Sr在缓解骨转移方面的相对疗效
J Nucl Med. 1999 Feb;40(2):256-61.
3
[Nuclear medicine therapy of bone metastases].骨转移瘤的核医学治疗
Rontgenblatter. 1983 Jul;36(7):216-9.
4
[The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].[89锶-氯化锶治疗200例前列腺癌骨转移患者的疗效]
Nuklearmedizin. 1992 Mar;31(2):48-52.
5
Bone pain palliation with 85Sr therapy.用85锶疗法缓解骨痛。
J Nucl Med. 1999 Apr;40(4):585-90.
6
Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.转移性前列腺癌锶-89放射治疗中的剂量估算
J Nucl Med. 1992 Jul;33(7):1316-23.
7
[Influence of 89Sr on the cell immune function in patients with multiple bone metastases].
Hunan Yi Ke Da Xue Xue Bao. 2002 Jun 28;27(3):277-8.
8
9
Decreased serum E-selectin concentration after 89Sr-chloride therapy for metastatic prostate cancer bone pain.
J Nucl Med. 2000 Jun;41(6):1021-4.
Zotero 插件